Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA1 | P00915 | 16/20 | 0.56 |
| ▸ | CA2 | P00918 | 16/20 | 0.56 |
| ▸ | CA9 | Q16790 | 15/20 | 0.56 |
| ▸ | CA12 | O43570 | 12/20 | 0.56 |
| ▸ | CA4 | P22748 | 3/20 | 0.49 |
| ▸ | CA7 | P43166 | 2/20 | 0.47 |
| ▸ | FYN | P06241 | 1/20 | 0.44 |
| ▸ | HTR1A | P08908 | 1/20 | 0.43 |
| ▸ | DRD3 | P35462 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7456278 | 0.85 | DRD3 (0.50) | FYNHTR1ADRD3 | |
| SCHEMBL7451624 | 0.84 | FYN (0.45) | FYNHTR1ADRD3 | |
| SCHEMBL8103965 | 0.84 | ALDH1A1 (0.55) | FYNHTR1ADRD3 | |
| SCHEMBL7456265 | 0.83 | DRD3 (0.54) | CA1CA2CA9CA4FYN | |
| SCHEMBL7451238 | 0.82 | DRD2 (0.51) | DRD3 | |
| SCHEMBL7443295 | 0.82 | FYN (0.45) | FYNHTR1ADRD3 | |
| SCHEMBL7448204 | 0.81 | FYN (0.42) | FYNHTR1ADRD3 | |
| SCHEMBL8094262 | 0.79 | CHRM5 (0.47) | DRD3 | |
| SCHEMBL7448699 | 0.79 | CA1 (0.49) | CA1CA2CA9CA4FYN | |
| SCHEMBL7459110 | 0.78 | ALDH1A1 (0.57) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6084130-A | FOR TREATMENT OF CENTRAL NERVOUS SYSTEM DISORDERS | PHARMACIA & UPJOHN COMPANY (US) | 2000-07-04 | — | — | US | disclosed |
| EP-0923542-A1 | ARYL SUBSTITUTED CYCLIC AMINES AS SELECTIVE DOPAMINE D3 LIGANDS | PHARMACIA & UPJOHN COMPANY (US) | 1999-06-23 | — | — | EP | disclosed |
| WO-1997045403-A1 | ARYL SUBSTITUTED CYCLIC AMINES AS SELECTIVE DOPAMINE D3 LIGANDS | PHARMACIA & UPJOHN COMPANY (US) | 1997-12-04 | — | — | WO | disclosed |